Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers for assessing idiopathic pulmonary fibrosis

Biomarkers for assessing idiopathic pulmonary fibrosis

US Patent 10036069 · Granted Jul 31, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for predicting lung function decline in idiopathic pulm2025
MicroRNA-33 inhibitors and use thereof in the treatment of pulmonary fibrosis2024
Use of tacrolimus in preparation of medicament for initiating tissue regeneratio2024
Biomarkers and methods of use for radiation-induced lung injury2023
Compositions and methods of treating or preventing fibrotic lung diseases2023
Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodies2022
Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodies2021
Coumarin-like cyclic compound as MEK inhibitor and use thereof2021
Method of treating one or more symptoms of pulmonary fibrosis by administering i2021
Method to reduce pulmonary arterial hypertension by administering inhibitors of 2021
Biomarkers for assessing idiopathic pulmonary fibrosis2021
Biomarkers for assessing idiopathic pulmonary fibrosis2021